Brian Thompson, the CEO of UnitedHealthcare, was reportedly investigated by the Department of Justice for insider trading when he was killed in New York City.
RELATED STORIES: Chilling New Photos of Murder Suspect Released — Masked Man Reportedly Used Silencer to Kill UnitedHealthcare CEO
On February 16, Thompson reviewed stock options and sold shares worth $15.1 million, just days before the Department of Justice (DOJ) announced its investigation into UnitedHealthcare’s acquisitions. The investigation focused on whether these deals unlawfully consolidated the company’s market dominance, potentially violating antitrust laws. The year 2024 has been quite turbulent for UnitedHealthcare, as it experienced one of the largest healthcare data breaches in U.S. history. This breach exposed sensitive data for one-third of the American population and forced the company to pay a ransom of $22 million to hackers, as reported by the New York Post.
Thompson was fatally shot in a targeted attack outside the Hilton hotel in Manhattan on Wednesday. Authorities reported that a masked gunman approached Thompson outside the hotel and fired at close range before fleeing into Central Park. The suspect is still at large, and police are actively searching for him. Thompson’s wife disclosed that he had been receiving threats prior to his death, but the motive for the shooting remains unclear.
RELATED STORIES: BREAKING: Brian Thompson, CEO of UnitedHealthcare, Shot and Killed in Shocking NYC Attack
Crain’s New York Business reported that Thompson’s stock sales were his first since he became CEO of the insurance division in 2021. The timing of these transactions, along with similar sales by other executives totaling $101.5 million, is attracting scrutiny. The company also suffered a financial fallout of $705 million from the data breach, leading it to face more significant challenges along with Thompson’s sudden death.
